SPI vs. ONT, GNS, CRW, UPR, PRTC, AMS, BMK, MXCT, NIOX, and INDV
Should you be buying Spire Healthcare Group stock or one of its competitors? The main competitors of Spire Healthcare Group include Oxford Nanopore Technologies (ONT), Genus (GNS), Craneware (CRW), Uniphar (UPR), PureTech Health (PRTC), Advanced Medical Solutions Group (AMS), Benchmark (BMK), MaxCyte (MXCT), NIOX Group (NIOX), and Indivior (INDV). These companies are all part of the "medical" sector.
Oxford Nanopore Technologies (LON:ONT) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, community ranking, profitability, institutional ownership, risk, analyst recommendations and valuation.
Spire Healthcare Group received 327 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 60.82% of users gave Spire Healthcare Group an outperform vote.
Oxford Nanopore Technologies presently has a consensus target price of GBX 303.75, suggesting a potential upside of 213.47%. Spire Healthcare Group has a consensus target price of GBX 302.25, suggesting a potential upside of 22.62%. Given Spire Healthcare Group's higher probable upside, research analysts plainly believe Oxford Nanopore Technologies is more favorable than Spire Healthcare Group.
Spire Healthcare Group has a net margin of 2.01% compared to Spire Healthcare Group's net margin of -91.06%. Oxford Nanopore Technologies' return on equity of 3.81% beat Spire Healthcare Group's return on equity.
In the previous week, Spire Healthcare Group had 3 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 4 mentions for Spire Healthcare Group and 1 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of -0.06 beat Spire Healthcare Group's score of -0.92 indicating that Spire Healthcare Group is being referred to more favorably in the news media.
Spire Healthcare Group has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Oxford Nanopore Technologies has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Comparatively, Spire Healthcare Group has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.
38.4% of Oxford Nanopore Technologies shares are owned by institutional investors. Comparatively, 44.8% of Spire Healthcare Group shares are owned by institutional investors. 30.1% of Oxford Nanopore Technologies shares are owned by insiders. Comparatively, 34.5% of Spire Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Spire Healthcare Group beats Oxford Nanopore Technologies on 13 of the 17 factors compared between the two stocks.
Get Spire Healthcare Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SPI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spire Healthcare Group Competitors List
Related Companies and Tools
